ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
126.134,94
-0,61%
S&P 500
6.040,53
-0,50%
US Dollar vs BRL
5,842
0,00%
Bitcoin
102.110,50
-0,30%
Brent Oil
76,385
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Telesis Bio Inc (TBIO)

  7. Telesis Bio Inc (TBIO) Notícias

TBIO

Telesis Bio (TBIO)

Telesis Bio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TBIO
DataHoraFonteTítuloCódigoCompanhia
07/01/202502:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TBIOTelesis Bio Inc
03/01/202518:20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:TBIOTelesis Bio Inc
08/11/202418:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
25/09/202417:05GlobeNewswire Inc.Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA SynthesisNASDAQ:TBIOTelesis Bio Inc
20/09/202418:02Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:TBIOTelesis Bio Inc
10/09/202417:30GlobeNewswire Inc.Telesis Bio Plans to Delist its Securities from The Nasdaq Stock MarketNASDAQ:TBIOTelesis Bio Inc
08/08/202407:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
07/08/202417:05GlobeNewswire Inc.Telesis Bio Reports Second Quarter and First Half 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
26/07/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
25/07/202417:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
18/07/202418:42Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
10/06/202421:40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
09/05/202417:05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/05/202417:05GlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
18/04/202410:00GlobeNewswire Inc.Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipNASDAQ:TBIOTelesis Bio Inc
28/03/202417:05GlobeNewswire Inc.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
26/02/202411:15GlobeNewswire Inc.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
13/11/202318:22GlobeNewswire Inc.Telesis Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
07/11/202311:00GlobeNewswire Inc.Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023NASDAQ:TBIOTelesis Bio Inc
03/11/202313:00GlobeNewswire Inc.Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNANASDAQ:TBIOTelesis Bio Inc
28/09/202316:48GlobeNewswire Inc.Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGSNASDAQ:TBIOTelesis Bio Inc
29/08/202317:05GlobeNewswire Inc.Telesis Bio Appoints William J. Kullback Chief Financial OfficerNASDAQ:TBIOTelesis Bio Inc
10/08/202317:05GlobeNewswire Inc.Telesis Bio Reports Second Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
03/08/202318:00GlobeNewswire Inc.Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023NASDAQ:TBIOTelesis Bio Inc
27/07/202318:28Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TBIOTelesis Bio Inc
08/06/202310:05GlobeNewswire Inc.Telesis Bio to Present at Jefferies Healthcare Conference 2023NASDAQ:TBIOTelesis Bio Inc
06/06/202304:00GlobeNewswire Inc.Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023NASDAQ:TBIOTelesis Bio Inc
05/06/202318:30GlobeNewswire Inc.Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common StockNASDAQ:TBIOTelesis Bio Inc
31/05/202318:29GlobeNewswire Inc.Telesis Bio Secures Financing of $28.0 MillionNASDAQ:TBIOTelesis Bio Inc
23/05/202310:00GlobeNewswire Inc.Telesis Bio to Present at SynBioBeta 2023NASDAQ:TBIOTelesis Bio Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TBIO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios